These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35747749)

  • 1. Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study.
    Massud A; Syed Sulaiman SA; Ahmad N; Shafqat M; Chiau Ming L; Khan AH
    Front Pharmacol; 2022; 13():883483. PubMed ID: 35747749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence, Management, and Risk Factors for Adverse Drug Reactions in Multidrug Resistant Tuberculosis Patients.
    Ahmad N; Javaid A; Syed Sulaiman SA; Afridi AK; Zainab ; Khan AH
    Am J Ther; 2018; 25(5):e533-e540. PubMed ID: 26938643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions in tuberculosis and management.
    Prasad R; Singh A; Gupta N
    Indian J Tuberc; 2019 Oct; 66(4):520-532. PubMed ID: 31813444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions of anti-tuberculosis treatment among children with tuberculosis.
    Laghari M; Talpur BA; Syed Sulaiman SA; Khan AH; Bhatti Z
    Int J Mycobacteriol; 2020; 9(3):281-288. PubMed ID: 32862161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse reactions due to directly observed treatment strategy therapy in Chinese tuberculosis patients: a prospective study.
    Lv X; Tang S; Xia Y; Wang X; Yuan Y; Hu D; Liu F; Wu S; Zhang Y; Yang Z; Tu D; Chen Y; Deng P; Ma Y; Chen R; Zhan S
    PLoS One; 2013; 8(6):e65037. PubMed ID: 23750225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study.
    Yang M; Pan H; Lu L; He X; Chen H; Tao B; Liu W; Yi H; Tang S
    BMJ Open; 2019 Mar; 9(3):e027321. PubMed ID: 30928962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, observational study of adverse reactions to drug regimen for multi-drug resistant pulmonary tuberculosis in central India.
    Hire R; Kale AS; Dakhale GN; Gaikwad N
    Mediterr J Hematol Infect Dis; 2014; 6(1):e2014061. PubMed ID: 25237474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and outcomes of adverse drug reactions to first-line anti-tuberculosis drugs and their effects on the quality of life: A multicenter prospective cohort study.
    Choi H; Park HA; Hyun IG; Kim JH; Hwang YI; Jang SH; Sim YS; Shin TR; Ko Y; Ban GY; Hong JY; Lee CY; Lee MG; Choi JH
    Pharmacoepidemiol Drug Saf; 2022 Nov; 31(11):1153-1163. PubMed ID: 35909258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ambispective study of adverse drug reactions in multi-drug resistant tuberculosis patients in Warangal, Telangana.
    Fatima S; Syeda MF; Adla N; Devi R
    Lung India; 2021; 38(4):330-337. PubMed ID: 34259171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Adverse Reactions Induced by Anti-Tuberculosis Drugs in Hospital Pulau Pinang.
    Fei CM; Zainal H; Ali IAH
    Malays J Med Sci; 2018 Sep; 25(5):103-114. PubMed ID: 30914867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and Factors Associated With Adverse Events Among Multi-Drug Resistant Tuberculosis Patients in Pakistan: A Retrospective Study.
    Atif M; Ahmed W; Nouman Iqbal M; Ahmad N; Ahmad W; Malik I; Al-Worafi YM
    Front Med (Lausanne); 2021; 8():790718. PubMed ID: 35300176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Adverse Drug Events, Their Risk Factors, and Management Among Patients Treated for Multidrug-Resistant TB: A Prospective Cohort Study From Pakistan.
    Khan FU; Khan A; Khan FU; Hayat K; Rehman AU; Chang J; Khalid W; Noor S; Khan A; Fang Y
    Front Pharmacol; 2022; 13():876955. PubMed ID: 35656303
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse drug reactions and treatment outcome analysis of DOTS-plus therapy of MDR-TB patients at district tuberculosis centre: A four year retrospective study.
    Dela AI; Tank NKD; Singh AP; Piparva KG
    Lung India; 2017; 34(6):522-526. PubMed ID: 29098997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug reaction and its management in tuberculosis patients with multidrug resistance: a retrospective study.
    Nilamsari WP; Rizqi MF; Regina NO; Wulaningrum PA; Fatmawati U
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):783-787. PubMed ID: 34214373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse drug reactions & drug interactions in MDR-TB patients.
    Gupta A; Kumar V; Natarajan S; Singla R
    Indian J Tuberc; 2020 Dec; 67(4S):S69-S78. PubMed ID: 33308674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug resistance patterns, treatment outcomes and factors affecting unfavourable treatment outcomes among extensively drug resistant tuberculosis patients in Pakistan; a multicentre record review.
    Atif M; Mukhtar S; Sarwar S; Naseem M; Malik I; Mushtaq A
    Saudi Pharm J; 2022 Apr; 30(4):462-469. PubMed ID: 35527826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions and risk factors for discontinuation of multidrug-resistant tuberculosis regimens in Gujarat, western India.
    Rupani MP; Dave JD; Parmar VB; Singh MP; Parikh KD
    Natl Med J India; 2020; 33(1):10-14. PubMed ID: 33565479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase
    Duga AL; Salvo F; Kay A; Figueras A
    Antibiotics (Basel); 2023 Apr; 12(5):. PubMed ID: 37237714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse reactions of anti-tuberculosis drugs in hospitalized patients: incidence, severity and risk factors.
    Javadi MR; Shalviri G; Gholami K; Salamzadeh J; Maghooli G; Mirsaeedi SM
    Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1104-10. PubMed ID: 17823987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of adverse events in patient receiving community-based therapy for multidrug-resistant tuberculosis in Pakistan.
    Javaid A; Khan MA; Jan F; Rauf M; Khan MA; Basit A; Mehreen S
    Tuberk Toraks; 2018 Mar; 66(1):16-25. PubMed ID: 30020037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.